$SIBN

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025 - SI-BONE (NASDAQ:SIBN)

SANTA CLARA, Calif., Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- SI-BONE, Inc. ( NASDAQ:SIBN ) , a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York, NY. ...

Original reporting
Benzinga · Globe Newswire
Published Nov 18, 2025, 9:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 18, 2025, 9:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025 - SI-BONE (NASDAQ:SIBN) — source image
Decision brief

The 30-second read

$SIBNBullishMed
01

Why it matters

The conference presentation is a strategic move to attract investor attention and potentially boost stock performance.

02

Market read

The event is significant within the healthcare investment community, especially for stakeholders interested in innovative medical devices.

03

What to watch

Broader market volatility and sector-specific challenges could overshadow positive conference effects.

Timing: High (event scheduled for December 2, 2025)

Background

SI-BONE specializes in medical devices for sacropelvic disorders, with ongoing efforts to increase visibility through industry conferences.

Company-level read

Ticker impact

$SIBNBullishMedium confidence
Context

The news pertains directly to SI-BONE's upcoming presentation at a major healthcare conference, which could influence investor sentiment and stock performance.

Expected impact

Moderate upward movement expected in the short term, contingent on conference outcomes.

Evidence & confidence

The event suggests positive visibility; however, actual impact depends on the company's performance and market conditions at the time.

Market effects

Potential positive sentiment for the medical device sector, especially companies focused on sacropelvic disorders.

Primarily affecting the U.S. healthcare and biotech sectors.

Limited; primarily relevant to U.S.-based investors and healthcare markets.

Counterpoint

The presentation may not lead to significant stock movement if market conditions are unfavorable or if the company's performance does not meet expectations.

Key entities

  • SI-BONE, Inc.

    A medical device company focused on sacropelvic disorder solutions.

  • Piper Sandler 37th Annual Healthcare Conference

    A major industry conference where SI-BONE will present.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_q226earningsrel.htm EX-99.1 Document Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Q

$LMTMedAI 8/10

What is Patriot missile system, why its supplies are down

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.